The T cells were co-cultured overnight with tumor target cells using a panel of STEAP1-positive (22Rv1, C2-4B, LNCap) and STEAP1-negative (22Rv1 STEAP1 knockout) prostate cancer cells that we have previously described [13,36]. The gene discussed is STEAP1; the disease is prostate cancer.